- Home
- ARBB vs LSTA Comparison
ARBB vs LSTA Comparison
Compare ARBB & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- LSTA
- Stock Information
- Founded
- ARBB 1997
- LSTA 1980
- Country
- ARBB Singapore
- LSTA United States
- Employees
- ARBB N/A
- LSTA N/A
- Industry
- ARBB EDP Services
- LSTA Misc Health and Biotechnology Services
- Sector
- ARBB Technology
- LSTA Health Care
- Exchange
- ARBB Nasdaq
- LSTA Nasdaq
- Market Cap
- ARBB 18.0M
- LSTA 20.0M
- IPO Year
- ARBB 2023
- LSTA N/A
- Fundamental
- Price
- ARBB $0.69
- LSTA $2.10
- Analyst Decision
- ARBB
- LSTA Strong Buy
- Analyst Count
- ARBB 0
- LSTA 1
- Target Price
- ARBB N/A
- LSTA $15.00
- AVG Volume (30 Days)
- ARBB 4.6M
- LSTA 10.1K
- Earning Date
- ARBB 05-16-2025
- LSTA 05-08-2025
- Dividend Yield
- ARBB N/A
- LSTA N/A
- EPS Growth
- ARBB N/A
- LSTA N/A
- EPS
- ARBB N/A
- LSTA N/A
- Revenue
- ARBB $24,425,491.00
- LSTA $1,000,000.00
- Revenue This Year
- ARBB N/A
- LSTA N/A
- Revenue Next Year
- ARBB N/A
- LSTA N/A
- P/E Ratio
- ARBB N/A
- LSTA N/A
- Revenue Growth
- ARBB N/A
- LSTA N/A
- 52 Week Low
- ARBB $0.22
- LSTA $1.87
- 52 Week High
- ARBB $1.24
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- ARBB 49.32
- LSTA 39.57
- Support Level
- ARBB $0.65
- LSTA $2.30
- Resistance Level
- ARBB $0.73
- LSTA $2.46
- Average True Range (ATR)
- ARBB 0.05
- LSTA 0.16
- MACD
- ARBB -0.00
- LSTA -0.02
- Stochastic Oscillator
- ARBB 27.38
- LSTA 6.25
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.